MedTrace Logo

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools

NCT01775332 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-07-31

No results posted yet for this study

Summary

The purpose of this research study is to determine the utility of educational materials designed to inform patients of their pituitary condition, in an effort to assist the patients, families, and staff deal with pituitary tumours and related conditions in the best way possible. We have developed a website, informational videos, and a brochure for pituitary tumour patients and their families. The primary outcome measures will be 1) the level of knowledge that patients have of their condition before and after reviewing the materials provided; and 2) ease of use and user satisfaction of the materials. We hypothesize that our informative multimedia educational package will not only improve the health literacy and self-efficacy of patients and their families, but will also improve quality of care.

Conditions

  • Pituitary Neoplasms
  • Prolactinoma
  • ACTH-Secreting Pituitary Adenoma
  • Gigantism
  • Growth Hormone-Secreting Pituitary Adenoma

Interventions

OTHER

Educational Intervention

A brochure and access to a website including videos that contain detailed information about pituitary disorders will serve as the educational intervention.

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Michael Cusimano, MD, PhD · Unity Health Toronto

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01775332 on ClinicalTrials.gov